Immunohistochemical Features of Different Types of Unstable Atherosclerotic Plaques of Coronary Arteries


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We performed a complex morphological study of samples of different types of unstable atherosclerotic plaques obtained from 33 men with occlusive coronary atherosclerosis, who underwent coronary artery endarterectomy during coronary artery bypass surgery. In the samples, expression of MMP-2 and MMP-9, collagen IV, CD31, CD34, factor VIII, and actin of smooth muscle cells was evaluated by morphometric and immunohistochemical methods. The maximum expression of MMP-9 was found in unstable plaques of the lipid type, where it 1.4- and 1.24-fold surpassed the corresponding levels in plaques of the inflammatory-erosive and degenerative-necrotic types. Unstable plaques of the degenerative-necrotic type are characterized by the most intensive expression of collagen IV in comparison with plaques of the inflammatory-erosive and lipid types (by 2.8 and 2.2 times, respectively). The maximum neovascularization was detected in inflammatory-erosive plaques, which was confirmed by enhanced expression of CD31 and CD34 markers in comparison with plaques of the lipid (by 7.6 and 18.95 times, respectively) and degenerative-necrotic (by 31.1 and 39.8 times) types.

About the authors

I. S. Murashov

Institute of Molecular Pathology and Pathomorphology, Federal Research Center of Fundamental and Translational Medicine; E. N. Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation

Author for correspondence.
Email: pathol@inbox.ru
Russian Federation, Novosibirsk; Novosibirsk

A. M. Volkov

E. N. Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation

Email: pathol@inbox.ru
Russian Federation, Novosibirsk

G. M. Kazanskaya

E. N. Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation

Email: pathol@inbox.ru
Russian Federation, Novosibirsk

E. E. Kliver

E. N. Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation

Email: pathol@inbox.ru
Russian Federation, Novosibirsk

A. M. Chernyavsky

E. N. Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation

Email: pathol@inbox.ru
Russian Federation, Novosibirsk

D. B. Nikityuk

Institute of Molecular Pathology and Pathomorphology, Federal Research Center of Fundamental and Translational Medicine

Email: pathol@inbox.ru
Russian Federation, Novosibirsk

E. L. Lushnikova

Institute of Molecular Pathology and Pathomorphology, Federal Research Center of Fundamental and Translational Medicine

Email: pathol@inbox.ru
Russian Federation, Novosibirsk


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies